Apaxen names new chairman
19 July 2022 -

Apaxen SA, a privately-held biotechnology company, announced on Monday that it has named Graham K Dixon, PhD as its chairman of its board of directors.

Dixon has held top management positions at companies such as Galapagos, Addex Therapeutics and Mithra Pharmaceutical, where he was instrumental in the regulatory approval of three pharmaceutical products, twelve proof of concept studies and ten clinical stage licensing deals. He serves as an experienced non-executive director and board chairman and an advisor to various venture capital organisations and their portfolio companies.

Bart Wuurman, Apaxen CEO, said, 'We are very pleased to welcome Graham as chairman of Apaxen's board of directors with his experience and extensive track record of leading biotechnology companies through strategic periods of growth. He will be a great asset for the company entering its phase of clinical development and we look forward to working with him.'